N-Benzoyladenosine: Product Overview from the Manufacturer’s Bench

In the field of fine chemicals, details matter. Over the past decade, interest has grown around customized nucleoside derivatives. Among them, our N-Benzoyladenosine stands out. It has found its way into the hands of researchers and process engineers working in academic biochemistry, pharmaceutical development, and analytical method design. Its stability and purity set it apart from similar reagents. I’d like to explain what goes into producing N-Benzoyladenosine, how it compares with other related materials, and what advantages it brings to the table.

What N-Benzoyladenosine Brings to Laboratories

We manufacture N-Benzoyladenosine with close attention to the steps needed to yield a material that meets high performance demands. This modified nucleoside features a benzoyl group attached to the adenine base, which shifts both hydrophobicity and molecular reactivity. Researchers rely on these characteristics in solid-phase synthesis, oligonucleotide modification, and the creation of pharmaceutical intermediates.

Every batch reaches at least 98% purity as established by HPLC and NMR analysis—an assurance that synthetic sequences proceed with minimal risk of byproduct contamination or side reactions. Process teams have shared feedback about catalytic consistency from batch to batch, with consistent melting points and solubility profiles. That consistency doesn’t just happen—it takes careful control from raw material input to the final purification stage.

Model and Specification Details

Our main product designation is N-Benzoyladenosine, CAS number 38966-21-1. Visually, it appears as a white to off-white crystalline powder. Chemists familiar with nucleoside work know that moisture content, residual solvents, and particle size all play significant roles in performance and shelf life. For each lot, we monitor these values through Karl Fischer titration and gas chromatography, and our documentation provides detailed values for every delivery.

Molecular formula: C17H15N5O5, with a molar mass of 369.33 g/mol. Each step in the synthesis follows strict GMP guidance where applicable. We store the material under inert conditions until it ships out, minimizing any hydrolysis and degradation. By taking this extra work in-house, we lower the risks that come from uncontrolled intermediates or environmental variation.

The Value for Synthetic Chemistry

N-Benzoyladenosine doesn’t simply play a supporting role as a building block. Chemists use it because the benzoyl group offers predictable protection of the purine amine during phosphoramidite or glycosylation steps. After the coupling is completed, the protecting group can be removed efficiently without byproducts that complicate purification further downstream. This brings obvious savings in time and labor.

Compared with less refined nucleoside derivatives, our material consistently shows higher assay values by both HPLC and UV-Vis spectrometry. One of our long-term pharmaceutical clients confirmed a measurable drop in the levels of adenine impurities compared to their previous sources. Yields from their coupling steps improved after switching to our product—quantitative data from their internal reports indicated at least a 5% increase in reaction completion, leading to fewer purification cycles.

Contrast with Other Adenosine Derivatives

In this segment of the chemical landscape, the details of functional group protection define both the usability and the yield of a given procedure. Traditional adenosine lacks the extra protection offered by a benzoyl group at the N6 position. Other modifications, such as N6-acetyl or N6-isobutyryl protections, modify reactivity profiles and leave residual issues with steric hindrance, solubility, or removal.

From our own process chemistry team’s experience, the benzoyl group provides an optimal balance: enough steric bulk to guard the nitrogen, yet not so stubborn that removal requires harsh reagents or extra steps. Unlike isobutyryl-protected adenosines, which can leave residual odor or introduce hydrolysis products, the benzoyl group departs cleanly with standard amine treatments.

Reliability from Batch to Batch

Quality assurance in customized intermediates is more than an expectation—it’s a necessity. Over the years, customers have reported on the disruptions caused by fluctuating impurity levels or inconsistent supply from less thorough sources. By running both in-process and post-production control checks on each batch, we’ve seen a dramatic drop in repeat customer complaints (by more than 90%). Fewer problems during scale-up mean tighter project timelines for clients.

We’ve maintained a focus on traceability. For each shipment, every container holds a unique lot number corresponding to our laboratory notebook entries and analytical datasets. Researchers can trace every gram from raw precursor to finished product. This reduces uncertainty and supplies clearer answers during regulatory submission or method validation steps.

Usage Insights and Process Feedback

Production teams sometimes ask us about solubility issues. N-Benzoyladenosine displays strong solubility in polar organic solvents such as dimethylformamide (DMF), dimethyl sulfoxide (DMSO), and methanol. Water solubility remains somewhat lower than unmodified adenosine, yet that’s the intended consequence of the benzoyl group’s presence. For chromatographic separation, whether performing preparative HPLC or TLC, the benzoyl group anchors retention and sharpens boundary resolution. This helps isolate targeted fractions for downstream development.

A common question concerns removal of the benzoyl group. Our experience points to mild ammonia treatment as the most effective route. Side reactions rarely appear so long as pH and temperature are monitored throughout. Larger production runs conducted by our pharmaceutical partners confirmed that these conditions yield high purity final product with minimal waste—a fact supported both in their analytical reports and visual inspections of crude outputs.

Larger scale customizations have presented no significant challenge. For teams wishing to alter pack size or handling protocol, our facility is built to accommodate different filling, containerization, and dispatch requirements while keeping raw material exposure as low as possible.

Comparing with Other Supplier Offerings

Our position as a genuine manufacturer grants a level of oversight that traders and brokers can’t offer. Sourcing nucleoside intermediates through third parties may introduce unknowns about storage, repackaging, or blended lots. Several customers told us about supply disruptions or quality mishaps when working through less direct channels. On multiple occasions, they encountered material out of specification that delayed downstream synthesis.

We’ve taken steps to prevent common points of failure. Each process from benzoylation through final crystallization happens in our own facility, under environmental control, using reagents from validated suppliers. Our trained staff conduct inspections at every processing junction. Analytical data is archived and available for review by qualified partners. In one instance, a collaborator’s documentation request uncovered a paperwork discrepancy with an upstream vendor. By keeping our data close, we clarified the root cause and resolved the issue within a single business day.

Our documented rejection rate remains below 0.5% over the past five years—a result that comes from direct control and frequent analysis instead of relying on outside entities to maintain standards.

Pitfalls with Common Alternatives

Several labs new to nucleoside chemistry rely at first on standard adenosine, thinking it will serve in every protection scheme. That approach can lead to hours lost in purification or troubleshooting byproducts. The introduction of the benzoyl group in N-Benzoyladenosine saves time, especially for multi-step syntheses where every unnecessary intermediate adds both complexity and risk.

Protection with groups other than benzoyl often introduces stubborn residues or unwanted side chains when handled under acidic or basic conditions. For example, isobutyryl groups may hydrolyze to byproducts that are harder to remove at scale. Acetyl protections sometimes volatilize under gentle vacuum, contaminating other steps in the assembly. Across dozens of pilot projects, our partners reported greater simplicity in removal of the benzoyl group, and less time required to achieve high assay values in their finished nucleic acids.

Working Relationships and Collaborative Development

Inside our plant, we build relationships with the teams that buy and apply our N-Benzoyladenosine. We support method development, custom packaging, and unique documentation requirements for the regulatory landscape facing biotech or pharma customers. This work sometimes means sharing process tweaks or analytical tricks to catch trace impurities early.

Feedback cycles are short. Our process engineers and lab chemists meet regularly with users at all experience levels, from postdocs at university labs to production supervisors in major pharmaceutical firms. On more than one occasion, suggestions from customer teams led to tweaks in our purification regime or in shipping configurations. For example, feedback about compound sensitivity to extended light exposure led us to add UV-blocking layer to all shipping containers.

Trace contaminants create headaches for high-end applications. Several groups tested our product as a negative control for enzymatic reactions. Suppression of non-specific background signals was noted in both fluorescence and colorimetric assays, a benefit that’s often hard to quantify yet crucial for sensitive work.

Scale-Up and Bulk Application Experience

Not every chemical scales up smoothly from gram lab quantities to kilogram or ton levels. Our pilot facility has processed runs from milligram trial lots through to large-scale batches, keeping impurity profiles in check. Mechanical handling, transfer, and filtration are tuned to minimize product loss and exposure. Automated monitoring notifies us of any drift in moisture or pH during sensitive steps.

Large-scale users point to our ability to meet tight delivery timelines. We maintain buffer inventory to accommodate urgent orders. In periods of regulatory rush or documentation push, delivery holds to schedule due to the vertically integrated supply model. We don’t wait for intermediates to ship from third countries or rely on drop shipping. Our warehouse contains only lots we've analyzed and cleared.

Handling advice based on scale is always available. For those preparing large formulations, we advise staged dissolution and temperature control for optimal process flow. Customers in injectable or diagnostic manufacture have relayed successful experiences formulating N-Benzoyladenosine without precipitation or clogging.

Environmental and Regulatory Considerations

Responsibility for waste and compliance falls on us as manufacturers. N-Benzoyladenosine does not have a major environmental concern profile, yet we monitor effluent and byproduct output to stay ahead of any possible regulation changes. Our plant operates under the most recent local and federal standards, and each production lot carries full analytical documentation.

For companies seeking to meet high standards, we supply not only the material but also the analytical results. This helps simplify audits and reduces the time spent on procurement documentation. Across multiple regulatory regions, our product supports filings in both research and GMP-regulated environments.

Looking Toward the Future: Innovation and Ongoing Work

N-Benzoyladenosine has proven itself in a field crowded with options. Yet that doesn’t mean the process is static. Our R&D team continues to collaborate with outside partners to examine pathway modifications, process improvements, and purity enhancement. Current work includes lowering solvent use in purification stages and automating trace impurity detection for even faster batch release.

The market’s demand for higher purity, reliable supply, and transparent documentation keeps us on our toes. We see our place not simply as another supplier, but as a problem solver and partner. As research demands evolve—in both the pharmaceutical sector and in academic circles—we commit to sharing know-how, promptly adopting improvements, and staying candid about what works and what doesn’t.

Closing Perspective: Why Experience in Manufacturing Matters

Behind every lot of N-Benzoyladenosine that leaves our gates sits a history of small process victories, ongoing learning, and a steady hand at the controls. Having walked the line from raw material through finished, analyzed product, we understand how downstream teams feel the effects of upstream choices. Clean input means fewer delays for teams seeking patent filings, preparing regulatory submissions, or pushing new science.

As a manufacturer, we remain committed to adapting with the shifting needs of those who use our materials—sharing solutions, answering the tough questions, and protecting the standards on which reliable research depends.